Harmony Biosciences stock hits 52-week low at $25.95
NegativeFinancial Markets

Harmony Biosciences has seen its stock price drop to a 52-week low of $25.95, raising concerns among investors about the company's future performance. This decline reflects broader market trends and may impact investor confidence, making it a significant event to watch in the biotech sector.
— Curated by the World Pulse Now AI Editorial System